Consistent with these findings, we found that ST6Gal-I knockdown inhibited the PI3K/Akt/GSK-3β/β-catenin signaling pathway, resulting in the suppression of malignant PCa cell phenotypes. The gene discussed is GSK3B; the disease is posterior cortical atrophy.